Detalhe da pesquisa
1.
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
BJU Int;
2024 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38839570
2.
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Lancet Oncol;
22(11): 1618-1631, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34678156
3.
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
J Med Genet;
57(4): 226-236, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31719169
4.
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
Br J Cancer;
118(2): 266-276, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29301143
5.
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
Br J Cancer;
118(6): e17, 2018 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29509747
6.
Hereditary renal cancer patient and public involvement group: A collaborative, consensus decision process to develop a communication tool for patient use.
J Clin Transl Sci;
7(1): e115, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37250990
7.
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Eur Urol;
76(6): 831-842, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31537406
8.
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.
Fam Cancer;
16(3): 433-440, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28091804